The effect of tyrosine kinase inhibitor on outcome of allogeneic hematopoietic stem cell transplant for the treatment of chronic myeloid leukaemia.
10.3760/cma.j.issn.0253-2727.2014.02.003
- Author:
Lanping XU
1
;
Yanru MA
1
Author Information
1. Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Hematopoietic Stem Cell Transplantation;
methods;
Humans;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
therapy;
Protein Kinase Inhibitors;
therapeutic use;
Protein-Tyrosine Kinases;
antagonists & inhibitors
- From:
Chinese Journal of Hematology
2014;35(2):94-95
- CountryChina
- Language:Chinese
